Familial Idiopathic Basal Ganglia Calcification |
|
|
Clinical Trial: Investigational Drug in Patients with Hypercholesterolemia or in Patients with Sitosterolemia
This study is no longer recruiting patients.
|
Purpose
The purpose of this study is to provide an investigational drug to patients with a specific type of hypercholesterolemia (high cholesterol) or sitosterolemia (unusually high absorption of non-cholesterol sterols) in a treatment use setting.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Hypercholesterolemia, Familial Lipid Metabolism, Inborn Errors | | Phase II Phase III |
MedlinePlus related topics: Cholesterol; Genetic Disorders; Metabolic Disorders
Study Type: Interventional
Study Design: Treatment, Safety Study
Official Title: A Treatment Study to Evaluate the Safety of An Investigational Drug in Patients with Hypercholesterolemia or in Patients with Sitosterolemia
Eligibility
Ages Eligible for Study: 8 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Homozygous familial hypercholesterolemia or sitosterolemia
Exclusion Criteria:
- Patient has a condition which, in the opinion of the investigator, might pose a risk to the patient, interfere with participation in the study, or does not meet the additional criteria as required by the study
Location Information
Pennsylvania
Call for Information, Horsham, Pennsylvania, 19044, United States
More Information
Record last reviewed: September 2004
Last Updated: October 13, 2004
Record first received: September 23, 2004
ClinicalTrials.gov Identifier: NCT00092833
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


